By integrating data from two distinct cohorts and utilizing advanced proteomic techniques, we have identified a specific group of proteins, including CA1, S100A6, and DDT, that demonstrate consistent upregulation in T2DM patients across both cohorts. Here, S100A6 is linked to type 2 diabetes mellitus.